Mark Kipnes
-
- Diabetes Treatment and Management 25
- Diabetes Management and Research 21
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Pharmacology top 2%
- Pharmacology and Obesity Treatment 6
- Hepatology top 5%
- Surgery top 2%
- Pancreatic function and diabetes 15
- Lipoproteins and Cardiovascular Health 4
- Oncology top 5%
-
- Diabetes and associated disorders 7
-
- Metabolism, Diabetes, and Cancer 7
- Co-authors
- Carolyn MickelJared LuncefordDebora Williams‐HermanPablo AschnerPeter SteinHootan KhatamiDebra FanurikKjeld Hermansen
- Journals
- Journal of Diabetes Science and Technology (5 papers)Diabetes Care (4 papers)Diabetes Obesity and Metabolism (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Kipnes
55 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Endocrinology, Diabetes and Metabolism 2.9k
- Pharmacology 577
- Hepatology 241
- Surgery 1.3k
- Oncology 717
Countries citing papers authored by Mark Kipnes
This map shows the geographic impact of Mark Kipnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kipnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kipnes more than expected).
Fields of papers citing papers by Mark Kipnes
This network shows the impact of papers produced by Mark Kipnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kipnes. The network helps show where Mark Kipnes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Kipnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetesbreakdown → | 2022 | 100 |
| 2 | 2021 | 1 | |
| 3 | Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Diseasebreakdown → | 2013 | 767 |
| 4 | 2012 | 75 | |
| 5 | 2011 | 34 | |
| 6 | 2011 | 14 | |
| 7 | 2010 | 8 | |
| 8 | 2009 | 18 | |
| 9 | A NEW THERAPY FOR NONALCOHOLIC FATTY LIVER DISEASE AND DIABETES? INT-747-THE FIRST FXR HEPATIC THERAPEUTIC STUDY | 2009 | 18 |
| 10 | 2009 | 43 | |
| 11 | 2008 | 143 | |
| 12 | 2007 | 432 | |
| 13 | 2007 | 1 | |
| 14 | 2006 | 77 | |
| 15 | 2004 | 31 | |
| 16 | 2004 | 70 | |
| 17 | 2002 | 44 | |
| 18 | 2001 | 222 | |
| 19 | 2001 | 6 | |
| 20 | 1998 | 114 |
About Mark Kipnes
Mark Kipnes is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Surgery, Pharmacology and Gastroenterology, having authored 57 papers that have together received 4.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (25 papers), Diabetes Management and Research (21 papers), Pancreatic function and diabetes (15 papers), Diabetes and associated disorders (7 papers), Metabolism, Diabetes, and Cancer (7 papers), Pharmacology and Obesity Treatment (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Pharmacology (577 citations), Hepatology (241 citations), Surgery (1.3k citations) and Oncology (717 citations). Mark Kipnes has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Carolyn Mickel, Jared Lunceford, Debora Williams‐Herman, Pablo Aschner, Peter Stein, Hootan Khatami, Debra Fanurik, Kjeld Hermansen, Sunder Mudaliar and Paul Dillon. Their work appears in journals such as Journal of Diabetes Science and Technology, Diabetes Care, Diabetes Obesity and Metabolism, Diabetes Technology & Therapeutics and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.